| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 6.85e-09 | 6 | 15 | 3 | GO:0015277 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.32e-07 | 17 | 15 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 2.78e-07 | 18 | 15 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.88e-07 | 24 | 15 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 9.92e-07 | 27 | 15 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | sodium channel activity | 7.41e-06 | 52 | 15 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 9.79e-06 | 57 | 15 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 1.10e-05 | 7 | 15 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.14e-05 | 60 | 15 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.46e-05 | 65 | 15 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.46e-05 | 65 | 15 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.24e-05 | 75 | 15 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.43e-05 | 77 | 15 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 5.31e-05 | 100 | 15 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.14e-05 | 105 | 15 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.11e-04 | 128 | 15 | 3 | GO:0005267 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.44e-04 | 140 | 15 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.43e-04 | 167 | 15 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.60e-04 | 171 | 15 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.71e-04 | 193 | 15 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.94e-04 | 197 | 15 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.56e-04 | 207 | 15 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.62e-04 | 208 | 15 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 4.67e-04 | 43 | 15 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.25e-03 | 293 | 15 | 3 | GO:0008514 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.82e-03 | 334 | 15 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.96e-03 | 343 | 15 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.17e-03 | 93 | 15 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.47e-03 | 459 | 15 | 3 | GO:0005216 | |
| GeneOntologyMolecularFunction | SNARE binding | 4.56e-03 | 136 | 15 | 2 | GO:0000149 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.63e-03 | 465 | 15 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 6.50e-03 | 525 | 15 | 3 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.53e-03 | 526 | 15 | 3 | GO:0022803 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 6.74e-03 | 532 | 15 | 3 | GO:0016755 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.06e-02 | 627 | 15 | 3 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.24e-02 | 664 | 15 | 3 | GO:0008324 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.76e-02 | 758 | 15 | 3 | GO:0015318 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.87e-02 | 775 | 15 | 3 | GO:0016746 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.99e-02 | 793 | 15 | 3 | GO:0015075 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 8.86e-08 | 13 | 15 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 9.01e-07 | 27 | 15 | 3 | GO:0035235 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 3.02e-06 | 40 | 15 | 3 | GO:1990806 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 9.87e-06 | 59 | 15 | 3 | GO:0007215 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 2.47e-05 | 80 | 15 | 3 | GO:0050805 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 3.76e-05 | 92 | 15 | 3 | GO:0051966 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.10e-04 | 132 | 15 | 3 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 1.13e-04 | 22 | 15 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 1.71e-04 | 27 | 15 | 2 | GO:0060080 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 2.42e-04 | 32 | 15 | 2 | GO:0099505 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.75e-04 | 180 | 15 | 3 | GO:0060078 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 3.79e-04 | 40 | 15 | 2 | GO:0048169 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.00e-03 | 65 | 15 | 2 | GO:0098815 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 1.06e-03 | 67 | 15 | 2 | GO:0099171 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 1.62e-03 | 83 | 15 | 2 | GO:0048168 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 5.97e-09 | 6 | 15 | 3 | GO:0032983 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.08e-06 | 29 | 15 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 4.17e-06 | 45 | 15 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 5.74e-06 | 50 | 15 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.67e-05 | 277 | 15 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | terminal bouton | 4.10e-05 | 96 | 15 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | potassium channel complex | 5.21e-05 | 104 | 15 | 3 | GO:0034705 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.77e-04 | 157 | 15 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 3.51e-04 | 39 | 15 | 2 | GO:0032839 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.66e-04 | 201 | 15 | 3 | GO:0099634 | |
| GeneOntologyCellularComponent | axon terminus | 4.16e-04 | 210 | 15 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.46e-04 | 530 | 15 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | neuron projection terminus | 5.63e-04 | 233 | 15 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | cation channel complex | 5.78e-04 | 235 | 15 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | receptor complex | 6.31e-04 | 581 | 15 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.40e-04 | 583 | 15 | 4 | GO:0097060 | |
| GeneOntologyCellularComponent | extracellular matrix | 9.95e-04 | 656 | 15 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.01e-03 | 658 | 15 | 4 | GO:0030312 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.82e-03 | 350 | 15 | 3 | GO:0098802 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.24e-03 | 817 | 15 | 4 | GO:0098978 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.27e-03 | 378 | 15 | 3 | GO:0034702 | |
| GeneOntologyCellularComponent | P-body | 2.38e-03 | 102 | 15 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 2.76e-03 | 110 | 15 | 2 | GO:0120111 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.76e-03 | 405 | 15 | 3 | GO:0045211 | |
| GeneOntologyCellularComponent | presynapse | 3.01e-03 | 886 | 15 | 4 | GO:0098793 | |
| GeneOntologyCellularComponent | axon | 3.07e-03 | 891 | 15 | 4 | GO:0030424 | |
| GeneOntologyCellularComponent | distal axon | 3.38e-03 | 435 | 15 | 3 | GO:0150034 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.74e-03 | 451 | 15 | 3 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.38e-03 | 477 | 15 | 3 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.08e-03 | 503 | 15 | 3 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 5.66e-03 | 523 | 15 | 3 | GO:0098984 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.66e-03 | 523 | 15 | 3 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 6.51e-03 | 550 | 15 | 3 | GO:1990351 | |
| GeneOntologyCellularComponent | perikaryon | 1.09e-02 | 223 | 15 | 2 | GO:0043204 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.55e-02 | 269 | 15 | 2 | GO:0036464 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.71e-02 | 785 | 15 | 3 | GO:0098797 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.75e-02 | 287 | 15 | 2 | GO:0035770 | |
| GeneOntologyCellularComponent | neuronal cell body | 2.02e-02 | 835 | 15 | 3 | GO:0043025 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.11e-02 | 317 | 15 | 2 | GO:0032838 | |
| GeneOntologyCellularComponent | dendrite | 2.17e-02 | 858 | 15 | 3 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 2.18e-02 | 860 | 15 | 3 | GO:0097447 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.30e-02 | 332 | 15 | 2 | GO:0005788 | |
| GeneOntologyCellularComponent | vacuole | 2.55e-02 | 913 | 15 | 3 | GO:0005773 | |
| GeneOntologyCellularComponent | cell body | 2.67e-02 | 929 | 15 | 3 | GO:0044297 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.68e-02 | 360 | 15 | 2 | GO:0099568 | |
| MousePheno | abnormal body length | 1.98e-05 | 550 | 10 | 5 | MP:0001256 | |
| MousePheno | decreased paired-pulse facilitation | 1.37e-04 | 25 | 10 | 2 | MP:0002920 | |
| MousePheno | decreased body length | 2.52e-04 | 484 | 10 | 4 | MP:0001258 | |
| MousePheno | abnormal long-term potentiation | 4.31e-04 | 221 | 10 | 3 | MP:0002207 | |
| MousePheno | abnormal glutamate-mediated receptor currents | 6.70e-04 | 55 | 10 | 2 | MP:0002886 | |
| Domain | PBPe | 3.40e-07 | 18 | 15 | 3 | SM00079 | |
| Domain | Iono_rcpt_met | 3.40e-07 | 18 | 15 | 3 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.40e-07 | 18 | 15 | 3 | IPR019594 | |
| Domain | Iontro_rcpt | 3.40e-07 | 18 | 15 | 3 | IPR001320 | |
| Domain | Lig_chan | 3.40e-07 | 18 | 15 | 3 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 3.40e-07 | 18 | 15 | 3 | SM00918 | |
| Domain | Lig_chan-Glu_bd | 3.40e-07 | 18 | 15 | 3 | PF10613 | |
| Domain | ANF_receptor | 3.20e-06 | 37 | 15 | 3 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 3.20e-06 | 37 | 15 | 3 | IPR001828 | |
| Domain | Peripla_BP_I | 3.76e-06 | 39 | 15 | 3 | IPR028082 | |
| Domain | Fibrinogen_C | 2.09e-04 | 27 | 15 | 2 | PF00147 | |
| Domain | FBG | 2.41e-04 | 29 | 15 | 2 | SM00186 | |
| Domain | - | 2.59e-04 | 30 | 15 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 2.59e-04 | 30 | 15 | 2 | IPR014716 | |
| Domain | FIBRINOGEN_C_2 | 2.94e-04 | 32 | 15 | 2 | PS51406 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.94e-04 | 32 | 15 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_1 | 2.94e-04 | 32 | 15 | 2 | PS00514 | |
| Domain | Ig_E-set | 3.08e-03 | 104 | 15 | 2 | IPR014756 | |
| Domain | Ank_2 | 1.25e-02 | 215 | 15 | 2 | PF12796 | |
| Domain | Ank | 1.40e-02 | 228 | 15 | 2 | PF00023 | |
| Domain | - | 1.47e-02 | 663 | 15 | 3 | 2.60.40.10 | |
| Domain | - | 1.65e-02 | 248 | 15 | 2 | 1.25.40.20 | |
| Domain | ANK | 1.68e-02 | 251 | 15 | 2 | SM00248 | |
| Domain | ANK_REPEAT | 1.71e-02 | 253 | 15 | 2 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.72e-02 | 254 | 15 | 2 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.72e-02 | 254 | 15 | 2 | PS50297 | |
| Domain | Ig-like_fold | 1.74e-02 | 706 | 15 | 3 | IPR013783 | |
| Domain | Ankyrin_rpt | 1.82e-02 | 262 | 15 | 2 | IPR002110 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 4.23e-08 | 10 | 11 | 3 | M10272 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 7.75e-08 | 12 | 11 | 3 | MM15142 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.42e-06 | 30 | 11 | 3 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.73e-06 | 32 | 11 | 3 | MM15143 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 1.39e-04 | 23 | 11 | 2 | MM14804 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.49e-04 | 140 | 11 | 3 | M42572 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 1.51e-04 | 24 | 11 | 2 | M636 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.62e-04 | 144 | 11 | 3 | MM14501 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 4.04e-04 | 39 | 11 | 2 | M48042 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.59e-04 | 205 | 11 | 3 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.99e-04 | 211 | 11 | 3 | MM14502 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 7.75e-04 | 54 | 11 | 2 | MM14633 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 8.63e-04 | 57 | 11 | 2 | M692 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 8.93e-04 | 58 | 11 | 2 | M576 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.02e-03 | 270 | 11 | 3 | M15514 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.05e-03 | 272 | 11 | 3 | M13380 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.90e-03 | 335 | 11 | 3 | MM14503 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 3.00e-03 | 107 | 11 | 2 | M14857 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.41e-03 | 411 | 11 | 3 | M735 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 3.94e-03 | 123 | 11 | 2 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 4.14e-03 | 126 | 11 | 2 | M695 | |
| Pubmed | 6.49e-11 | 3 | 15 | 3 | 31513786 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 6.49e-11 | 3 | 15 | 3 | 15805114 | |
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 6.49e-11 | 3 | 15 | 3 | 9880586 | |
| Pubmed | 2.60e-10 | 4 | 15 | 3 | 15513934 | ||
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 2.60e-10 | 4 | 15 | 3 | 30241548 | |
| Pubmed | 2.60e-10 | 4 | 15 | 3 | 19369569 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 6.49e-10 | 5 | 15 | 3 | 23076118 | |
| Pubmed | 6.49e-10 | 5 | 15 | 3 | 18358623 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 6.49e-10 | 5 | 15 | 3 | 18793656 | |
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 6.49e-10 | 5 | 15 | 3 | 9593973 | |
| Pubmed | 6.49e-10 | 5 | 15 | 3 | 28228252 | ||
| Pubmed | 6.49e-10 | 5 | 15 | 3 | 12223554 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 6.49e-10 | 5 | 15 | 3 | 29058671 | |
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.30e-09 | 6 | 15 | 3 | 28714086 | |
| Pubmed | 2.27e-09 | 7 | 15 | 3 | 19342380 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 2.27e-09 | 7 | 15 | 3 | 9651535 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 2.27e-09 | 7 | 15 | 3 | 9016303 | |
| Pubmed | 2.27e-09 | 7 | 15 | 3 | 1310861 | ||
| Pubmed | 2.27e-09 | 7 | 15 | 3 | 17428973 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 3.63e-09 | 8 | 15 | 3 | 8163463 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 5.44e-09 | 9 | 15 | 3 | 9051806 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.85e-08 | 13 | 15 | 3 | 20859245 | |
| Pubmed | 1.14e-07 | 23 | 15 | 3 | 8464923 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.31e-07 | 24 | 15 | 3 | 35746896 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 11182092 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 16219388 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 12947409 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 1.74e-07 | 2 | 15 | 2 | 8260617 | |
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 1.74e-07 | 2 | 15 | 2 | 15537878 | |
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 1.74e-07 | 2 | 15 | 2 | 24760837 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 15673679 | ||
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 1.74e-07 | 2 | 15 | 2 | 11144357 | |
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 1.74e-07 | 2 | 15 | 2 | 15928066 | |
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 1.74e-07 | 2 | 15 | 2 | 15483117 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 19320626 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 15358807 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 14724198 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 17620617 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 25043179 | ||
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 1.74e-07 | 2 | 15 | 2 | 11985817 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 15094479 | ||
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 1.74e-07 | 2 | 15 | 2 | 15014126 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 7696618 | ||
| Pubmed | Atypical functional properties of GluK3-containing kainate receptors. | 1.74e-07 | 2 | 15 | 2 | 20007474 | |
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 1.74e-07 | 2 | 15 | 2 | 8700852 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 11069933 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 15539395 | ||
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 1.74e-07 | 2 | 15 | 2 | 16221857 | |
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 5.21e-07 | 3 | 15 | 2 | 27346345 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 1379666 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 8730589 | ||
| Pubmed | RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. | 5.21e-07 | 3 | 15 | 2 | 7523595 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 32567721 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 7538211 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 15509753 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 17650106 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 16354929 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 26277340 | ||
| Pubmed | Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. | 1.04e-06 | 4 | 15 | 2 | 12954862 | |
| Pubmed | Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. | 1.04e-06 | 4 | 15 | 2 | 20081851 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 17174564 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 25556835 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 26448475 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 9466455 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 28854365 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 1.73e-06 | 5 | 15 | 2 | 1717158 | |
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 12597860 | ||
| Pubmed | The actin-binding protein Filamin-A interacts with the metabotropic glutamate receptor type 7. | 2.60e-06 | 6 | 15 | 2 | 11943148 | |
| Pubmed | Neto1 is an auxiliary subunit of native synaptic kainate receptors. | 2.60e-06 | 6 | 15 | 2 | 21734292 | |
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 39032541 | ||
| Pubmed | 5.43e-06 | 81 | 15 | 3 | 22723691 | ||
| Pubmed | 6.24e-06 | 9 | 15 | 2 | 34100982 | ||
| Pubmed | 1.14e-05 | 12 | 15 | 2 | 11891216 | ||
| Pubmed | Excitatory glutamate is essential for development and maintenance of the piloneural mechanoreceptor. | 1.82e-05 | 15 | 15 | 2 | 22241839 | |
| Pubmed | 2.08e-05 | 16 | 15 | 2 | 32414810 | ||
| Pubmed | 4.77e-05 | 24 | 15 | 2 | 22534482 | ||
| Pubmed | 2.68e-04 | 300 | 15 | 3 | 19086053 | ||
| Interaction | GRIK4 interactions | 1.86e-08 | 8 | 15 | 3 | int:GRIK4 | |
| Interaction | GRIK3 interactions | 3.99e-08 | 10 | 15 | 3 | int:GRIK3 | |
| Interaction | GRIK5 interactions | 3.77e-07 | 20 | 15 | 3 | int:GRIK5 | |
| Interaction | GRIK2 interactions | 1.63e-06 | 32 | 15 | 3 | int:GRIK2 | |
| Interaction | GRIK1 interactions | 2.35e-06 | 36 | 15 | 3 | int:GRIK1 | |
| Interaction | SCGB2A1 interactions | 5.81e-05 | 104 | 15 | 3 | int:SCGB2A1 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 3.69e-09 | 5 | 14 | 3 | 1199 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.32e-05 | 13 | 14 | 2 | 685 | |
| GeneFamily | Fibrinogen C domain containing | 1.65e-04 | 25 | 14 | 2 | 554 | |
| GeneFamily | Ankyrin repeat domain containing | 1.46e-02 | 242 | 14 | 2 | 403 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-05 | 131 | 15 | 3 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.67e-05 | 152 | 15 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.29e-05 | 169 | 15 | 3 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.29e-05 | 169 | 15 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.63e-05 | 177 | 15 | 3 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.91e-05 | 183 | 15 | 3 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 186 | 15 | 3 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.10e-05 | 187 | 15 | 3 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.10e-05 | 187 | 15 | 3 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-05 | 192 | 15 | 3 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-05 | 193 | 15 | 3 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 193 | 15 | 3 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-05 | 194 | 15 | 3 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 1a04331862079092bc04b1010aa9228c0fa3d8c5 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | fb56d430957e73fba17db7bc0127ecf3577e0867 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 05bcde6ce8f1354ef65e4eb9cbd963a92108081c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-05 | 200 | 15 | 3 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P1-P1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.56e-04 | 84 | 15 | 2 | db96d45e863d04a9b340c9229576d654dce85a3f | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.56e-04 | 84 | 15 | 2 | 152807da52b50713fc6fed2b2bef5d5762e9c0da | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.56e-04 | 84 | 15 | 2 | a88bdb8ea8a50df38fb740515d02aa87293e5d25 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-04 | 113 | 15 | 2 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.00e-04 | 118 | 15 | 2 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.36e-04 | 129 | 15 | 2 | 0dcce7cb95bb3593626ecb34ed9da58c7de4e016 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.36e-04 | 129 | 15 | 2 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.49e-04 | 130 | 15 | 2 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.88e-04 | 133 | 15 | 2 | b4e68a9a223e5188f1a00c7dc9bb2d675cde1d40 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.88e-04 | 133 | 15 | 2 | 8819fd897b97812355e1709fcc42754522d5fb27 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.28e-04 | 136 | 15 | 2 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.83e-04 | 140 | 15 | 2 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.97e-04 | 141 | 15 | 2 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-03 | 142 | 15 | 2 | 85e573616e54d41391b4ad8c3d38e4ca92112673 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-03 | 143 | 15 | 2 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.11e-03 | 149 | 15 | 2 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.11e-03 | 149 | 15 | 2 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 1.11e-03 | 149 | 15 | 2 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 153 | 15 | 2 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 1.17e-03 | 153 | 15 | 2 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 154 | 15 | 2 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 154 | 15 | 2 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.19e-03 | 154 | 15 | 2 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 154 | 15 | 2 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 154 | 15 | 2 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-03 | 155 | 15 | 2 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.22e-03 | 156 | 15 | 2 | 8353f98e7d393d4299ed1da8f66cfbc7176df1b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-03 | 156 | 15 | 2 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-03 | 156 | 15 | 2 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 157 | 15 | 2 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 157 | 15 | 2 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-03 | 157 | 15 | 2 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-03 | 157 | 15 | 2 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-03 | 160 | 15 | 2 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-03 | 160 | 15 | 2 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.28e-03 | 160 | 15 | 2 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-03 | 160 | 15 | 2 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-03 | 160 | 15 | 2 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.30e-03 | 161 | 15 | 2 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.30e-03 | 161 | 15 | 2 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | IPF-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 1.30e-03 | 161 | 15 | 2 | 133833729ba8b6d3eef326590ca7476b17602cbb | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-03 | 161 | 15 | 2 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 162 | 15 | 2 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.31e-03 | 162 | 15 | 2 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 162 | 15 | 2 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 162 | 15 | 2 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 162 | 15 | 2 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-03 | 162 | 15 | 2 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-03 | 163 | 15 | 2 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-03 | 164 | 15 | 2 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.36e-03 | 165 | 15 | 2 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-03 | 166 | 15 | 2 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-03 | 166 | 15 | 2 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-03 | 166 | 15 | 2 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-03 | 166 | 15 | 2 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-03 | 166 | 15 | 2 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-03 | 166 | 15 | 2 | eb9c81fa7573de7aff6670e7dad313f02129809f | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-03 | 167 | 15 | 2 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-03 | 167 | 15 | 2 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.39e-03 | 167 | 15 | 2 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| Computational | Ion channels. | 5.58e-05 | 70 | 12 | 3 | MODULE_316 | |
| Drug | LY339434 | 1.94e-08 | 9 | 15 | 3 | CID006324635 | |
| Drug | decahydroisoquinoline | 1.29e-07 | 16 | 15 | 3 | CID000097812 | |
| Drug | LY382884 | 2.23e-07 | 19 | 15 | 3 | CID000656723 | |
| Drug | NS 102 | 3.54e-07 | 22 | 15 | 3 | CID005282252 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 4.05e-07 | 2 | 15 | 2 | ctd:C084273 | |
| Drug | LY293558 | 9.29e-07 | 30 | 15 | 3 | CID000127894 | |
| Drug | 4-methylglutamic acid | 1.03e-06 | 31 | 15 | 3 | CID000005365 | |
| Drug | willardine | 1.13e-06 | 32 | 15 | 3 | CID000005123 | |
| Drug | L-BMAA | 1.92e-06 | 38 | 15 | 3 | CID000028558 | |
| Drug | DETC-MeSO | 2.08e-06 | 39 | 15 | 3 | CID003035711 | |
| Drug | aminothiazole 6 | 2.43e-06 | 4 | 15 | 2 | CID005329388 | |
| Drug | acromelic acid B | 2.43e-06 | 4 | 15 | 2 | CID000158974 | |
| Drug | Brn 1074551 | 2.43e-06 | 4 | 15 | 2 | CID000120220 | |
| Drug | diCl-HQC | 2.43e-06 | 4 | 15 | 2 | CID003018579 | |
| Drug | Joro spider toxin | 2.81e-06 | 43 | 15 | 3 | CID000119582 | |
| Drug | philanthotoxin | 3.23e-06 | 45 | 15 | 3 | CID000115201 | |
| Drug | 3-hydroxy-2-quinoxalinecarboxylic acid | 4.05e-06 | 5 | 15 | 2 | CID000071001 | |
| Drug | bromowillardiine | 4.05e-06 | 5 | 15 | 2 | CID000167842 | |
| Drug | ipenoxazone | 4.05e-06 | 5 | 15 | 2 | CID000065882 | |
| Drug | pBB-PzDA | 4.05e-06 | 5 | 15 | 2 | CID000124528 | |
| Drug | AC1L1FA8 | 4.45e-06 | 50 | 15 | 3 | CID000003150 | |
| Drug | LY354740 | 4.73e-06 | 51 | 15 | 3 | CID000114827 | |
| Drug | AC1L1EKQ | 5.01e-06 | 52 | 15 | 3 | CID000002834 | |
| Drug | 3-acetylisoquinoline | 6.07e-06 | 6 | 15 | 2 | CID000124656 | |
| Drug | GYKI 52466 | 6.98e-06 | 58 | 15 | 3 | CID000003538 | |
| Drug | 3,7-diaminoheptan-2-one | 8.14e-06 | 61 | 15 | 3 | CID004477684 | |
| Drug | fluorocyclobutane | 8.49e-06 | 7 | 15 | 2 | CID011051569 | |
| Drug | AC1L1J7N | 9.41e-06 | 64 | 15 | 3 | CID000004902 | |
| Drug | L-Glutamic Acid | 1.13e-05 | 68 | 15 | 3 | DB00142 | |
| Drug | AC1L1B65 | 1.13e-05 | 8 | 15 | 2 | CID000001300 | |
| Drug | perzinfotel | 1.13e-05 | 8 | 15 | 2 | CID006918236 | |
| Drug | felbamate | 1.23e-05 | 70 | 15 | 3 | CID000003331 | |
| Drug | Ly294486 | 1.45e-05 | 9 | 15 | 2 | CID005311255 | |
| Drug | 1m5b | 1.45e-05 | 9 | 15 | 2 | CID000447081 | |
| Drug | benzo(F)quinoxaline | 1.45e-05 | 9 | 15 | 2 | CID000098494 | |
| Drug | AC1L1E5T | 1.46e-05 | 74 | 15 | 3 | CID000002653 | |
| Drug | AC1L1DME | 1.52e-05 | 75 | 15 | 3 | CID000002414 | |
| Drug | HFPA | 1.82e-05 | 10 | 15 | 2 | CID003035614 | |
| Drug | Benzoates | 1.82e-05 | 10 | 15 | 2 | ctd:D001565 | |
| Drug | D-N-Q | 2.13e-05 | 84 | 15 | 3 | CID000003140 | |
| Drug | AC1L1BXF | 2.21e-05 | 85 | 15 | 3 | CID000001650 | |
| Drug | sym 2206 | 2.22e-05 | 11 | 15 | 2 | CID005039877 | |
| Drug | hexachlorophene | 2.63e-05 | 90 | 15 | 3 | CID000003598 | |
| Drug | Atpa | 2.66e-05 | 12 | 15 | 2 | CID000002252 | |
| Drug | aurintricarboxylic acid | 2.71e-05 | 91 | 15 | 3 | CID000002259 | |
| Drug | 1xa5 | 2.90e-05 | 93 | 15 | 3 | CID000157684 | |
| Drug | cyclothiazide | 3.93e-05 | 103 | 15 | 3 | CID000002910 | |
| Drug | ACEA-1011 | 4.23e-05 | 15 | 15 | 2 | CID000127872 | |
| Drug | argiopine | 4.84e-05 | 16 | 15 | 2 | CID000122294 | |
| Drug | 3HPG | 5.48e-05 | 17 | 15 | 2 | CID000001217 | |
| Drug | acromelic acid A | 6.16e-05 | 18 | 15 | 2 | CID000108086 | |
| Drug | kynurenic acid | 6.52e-05 | 122 | 15 | 3 | CID000003845 | |
| Drug | Linuron | 7.52e-05 | 128 | 15 | 3 | ctd:D008044 | |
| Drug | IDRA 21 | 7.64e-05 | 20 | 15 | 2 | CID000003688 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 7.64e-05 | 20 | 15 | 2 | CID000001297 | |
| Drug | aniracetam | 7.87e-05 | 130 | 15 | 3 | CID000002196 | |
| Drug | AC1L1B62 | 8.45e-05 | 21 | 15 | 2 | CID000001299 | |
| Drug | Celecoxib | 8.65e-05 | 376 | 15 | 4 | ctd:D000068579 | |
| Drug | CX516 | 9.29e-05 | 22 | 15 | 2 | CID000148184 | |
| Drug | haloperidol | 1.04e-04 | 394 | 15 | 4 | CID000003559 | |
| Drug | DE gel | 1.04e-04 | 143 | 15 | 3 | CID000008146 | |
| Drug | Ns102 | 1.20e-04 | 25 | 15 | 2 | CID005311098 | |
| Drug | putrescine | 1.28e-04 | 153 | 15 | 3 | CID000001045 | |
| Drug | procymidone | 1.33e-04 | 155 | 15 | 3 | ctd:C035988 | |
| Drug | 2-chloropropionate | 1.41e-04 | 27 | 15 | 2 | CID000011734 | |
| Drug | AC1NUW3V | 1.63e-04 | 29 | 15 | 2 | CID005462126 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 1.74e-04 | 30 | 15 | 2 | CID000001226 | |
| Drug | riluzole | 1.87e-04 | 174 | 15 | 3 | CID000005070 | |
| Drug | L-quisqualic acid | 2.06e-04 | 180 | 15 | 3 | CID000001209 | |
| Drug | TG-3 | 2.11e-04 | 33 | 15 | 2 | CID000205489 | |
| Drug | 6,7-dinitroquinoxaline | 2.11e-04 | 33 | 15 | 2 | CID002724608 | |
| Drug | CPPG | 2.25e-04 | 34 | 15 | 2 | CID000002878 | |
| Drug | kainite | 2.38e-04 | 35 | 15 | 2 | CID000164810 | |
| Drug | R,S)-AMPA | 2.52e-04 | 36 | 15 | 2 | CID000001221 | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | 2.53e-04 | 193 | 15 | 3 | 2682_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-04 | 193 | 15 | 3 | 5922_UP | |
| Drug | Kainic Acid | 2.57e-04 | 194 | 15 | 3 | ctd:D007608 | |
| Drug | Avermectin B1 [71751-41-2]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 6081_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 3610_UP | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 6367_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.65e-04 | 196 | 15 | 3 | 1021_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 3816_DN | |
| Drug | Diazoxide [364-98-7]; Up 200; 17.4uM; PC3; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 2052_UP | |
| Drug | gamma-Glu-Gly | 2.66e-04 | 37 | 15 | 2 | CID000100099 | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 5641_UP | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 4066_DN | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 5964_UP | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 6091_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 3885_DN | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 4099_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 6611_UP | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 4147_UP | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5639_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 1502_UP | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; HL60; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 6142_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 6629_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 3698_DN | |
| Drug | GAMs | 2.81e-04 | 38 | 15 | 2 | CID000002935 | |
| Drug | CGS 19755 | 2.81e-04 | 38 | 15 | 2 | CID000068736 | |
| Drug | 3-C-4 | 2.81e-04 | 38 | 15 | 2 | CID000118534 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.21e-05 | 145 | 13 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | Bilateral Wilms Tumor | 7.23e-05 | 29 | 13 | 2 | C2930471 | |
| Disease | Nephroblastoma | 1.12e-04 | 36 | 13 | 2 | C0027708 | |
| Disease | Alzheimer disease, APOE carrier status | 8.32e-04 | 98 | 13 | 2 | EFO_0007659, MONDO_0004975 | |
| Disease | ascending aortic diameter | 1.68e-03 | 140 | 13 | 2 | EFO_0021787 | |
| Disease | unipolar depression, bipolar disorder | 2.08e-03 | 156 | 13 | 2 | EFO_0003761, MONDO_0004985 | |
| Disease | risky sexual behaviour measurement | 2.44e-03 | 169 | 13 | 2 | EFO_0007877 | |
| Disease | aortic measurement | 5.28e-03 | 251 | 13 | 2 | EFO_0020865 | |
| Disease | Alcoholic Intoxication, Chronic | 6.00e-03 | 268 | 13 | 2 | C0001973 | |
| Disease | Schizophrenia | 6.10e-03 | 883 | 13 | 3 | C0036341 | |
| Disease | neuroticism measurement | 6.61e-03 | 909 | 13 | 3 | EFO_0007660 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGKYGAQNDKGEWNG | 501 | P39086 | |
| GEKGTKNGQFNYPWD | 691 | Q2Q1W2 | |
| GNGNEDDCWNGKGKS | 416 | O75487 | |
| ENFNRGWKDYENGFG | 131 | Q08830 | |
| GWKDYENGFGNFVQK | 136 | Q08830 | |
| WYGGCGGNENKFGSQ | 3141 | P12111 | |
| GGTNFGYWNGADKKG | 306 | Q6UWU2 | |
| QGNKADYPEGDGNWA | 116 | Q8WWU7 | |
| GKYGAQDDANGQWNG | 486 | Q13002 | |
| VEDGKYGAQDDKGQW | 486 | Q13003 | |
| YGAQDDKGQWNGMVK | 491 | Q13003 | |
| GYHNWGNKEERDGKD | 316 | Q96FA3 | |
| GSGKSNVGAWGDYDD | 111 | B2RU33 | |
| NGIYKGGKANNWEGG | 361 | P08842 | |
| GSGKSNVGAWGDYDD | 111 | P0CG38 | |
| NGVLQGNWGEDYSKG | 236 | Q96PF1 | |
| DPKNTGGWNDYKNNN | 691 | Q9UPQ9 |